5,613 Shares in The New York Times Company (NYSE:NYT) Purchased by PharVision Advisers LLC

PharVision Advisers LLC acquired a new stake in The New York Times Company (NYSE:NYT) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 5,613 shares of the company’s stock, valued at approximately $292,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of New York Times by 511.7% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 471 shares of the company’s stock worth $25,000 after purchasing an additional 394 shares in the last quarter. Mountain Hill Investment Partners Corp. acquired a new position in New York Times during the 4th quarter worth $36,000. UMB Bank n.a. boosted its position in New York Times by 61.4% in the 4th quarter. UMB Bank n.a. now owns 744 shares of the company’s stock valued at $39,000 after buying an additional 283 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in New York Times by 27.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,140 shares of the company’s stock valued at $60,000 after buying an additional 247 shares during the last quarter. Finally, Bessemer Group Inc. increased its stake in shares of New York Times by 12.6% in the 4th quarter. Bessemer Group Inc. now owns 1,895 shares of the company’s stock valued at $99,000 after buying an additional 212 shares during the period. Institutional investors and hedge funds own 95.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on NYT. StockNews.com upgraded New York Times from a “hold” rating to a “buy” rating in a report on Friday, April 11th. Guggenheim upped their target price on shares of New York Times from $52.00 to $53.00 and gave the company a “neutral” rating in a research report on Thursday, May 8th. Finally, Morgan Stanley reduced their target price on shares of New York Times from $56.00 to $54.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, New York Times currently has an average rating of “Moderate Buy” and a consensus price target of $56.00.

New York Times Stock Down 1.0%

NYSE:NYT opened at $54.80 on Thursday. The New York Times Company has a 12-month low of $44.83 and a 12-month high of $58.16. The stock’s fifty day simple moving average is $50.46 and its 200-day simple moving average is $51.59. The firm has a market capitalization of $8.94 billion, a P/E ratio of 30.79, a P/E/G ratio of 1.75 and a beta of 1.16.

New York Times (NYSE:NYT) last released its earnings results on Wednesday, May 7th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.06. The firm had revenue of $635.91 million for the quarter, compared to analyst estimates of $634.99 million. New York Times had a return on equity of 18.51% and a net margin of 11.36%. The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.31 earnings per share. As a group, equities research analysts expect that The New York Times Company will post 2.08 earnings per share for the current year.

About New York Times

The New York Times Company, together with its subsidiaries, creates, collects, and distributes news and information worldwide. The company operates through two segments, The New York Times Group and The Athletic. It offers The New York Times (The Times) through company’s mobile application, website, printed newspaper, and associated content, such as podcast.